Glaucoma Physician

4 weeks ago | glaucomaphysician.net | Karen Appold

Inder Paul Singh, MD, a glaucoma surgeon and the president of The Eye Centers of Racine and Kenosha in Wisconsin, was eager to try Alcon’s new Voyager Direct Selective Laser Trabeculoplasty (DSLT) system at his practice, because data indicate that SLT is a better first-line treatment for most glaucoma patients than topical drops. He maintains that DSLT is a win-win for patients and physicians. “SLT can’t be used on some patients who have angles that are difficult to view,” he says.

Nov 1, 2024 | glaucomaphysician.net | Constance Okeke

In ophthalmology, the administration of topical medications is a cornerstone for glaucoma management. However, commercially available drop sizes (30+ µL) exceed the eye’s capacity to retain the medication (7-10 µL), leading to excessive dosing, overflow, periorbital irritation, and drainage by the nasolacrimal ducts causing systemic absorption. The increased risk of systemic adverse effects (AEs), particularly with drug classes like beta-blockers, has additional implications for patient safety.

Oct 31, 2024 | glaucomaphysician.net | Sahar Bedrood

Over the last decade, there has been a renaissance in glaucoma surgical treatment options when it comes to angle surgery as well as devices that can help encourage outflow through the trabecular meshwork.

Oct 31, 2024 | glaucomaphysician.net | Zarmeena Vendal

Traditionally, the surgical space for cataract surgery has been very limited for primary open-angle glaucoma (POAG) patients. Fortunately, today we are on the forefront of innovation when it comes to finding a solution for these patients, because there are multiple lens implant choices that can help us push limits and provide satisfying visual outcomes.

Oct 31, 2024 | glaucomaphysician.net | Nathan M. Radcliffe

How does one treat glaucoma? Of course, the only proven therapy at this point in time is lowering intraocular pressure (IOP). My favorite answer to this question has always been that the goal of glaucoma treatment is to maintain the patient’s vision-related quality of life without decreasing the patient’s quality of life. With this goal in mind, the practical answer is to lower IOP in a way that maximizes the patient’s overall quality of life.